KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $45,354,000 | +6.8% | 252,234 | -38.4% | 0.05% | +4.5% |
| Q2 2017 | $42,474,000 | +11.8% | 409,707 | -15.4% | 0.04% | +12.8% |
| Q1 2017 | $37,998,000 | +43.5% | 484,109 | -18.0% | 0.04% | +34.5% |
| Q4 2016 | $26,471,000 | +36.9% | 590,343 | +70.5% | 0.03% | +38.1% |
| Q3 2016 | $19,337,000 | +28.8% | 346,171 | +15.3% | 0.02% | +23.5% |
| Q2 2016 | $15,008,000 | +15.3% | 300,160 | +5.8% | 0.02% | +13.3% |
| Q1 2016 | $13,020,000 | -26.0% | 283,601 | -0.7% | 0.02% | -28.6% |
| Q4 2015 | $17,595,000 | +16.5% | 285,536 | +5.3% | 0.02% | +16.7% |
| Q3 2015 | $15,104,000 | -6.0% | 271,266 | +3.0% | 0.02% | 0.0% |
| Q2 2015 | $16,060,000 | – | 263,415 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |